Associate Professor, Cardiology, Baylor College of Medicine
Cardiology
Dr. Anita Deswal, MD
|
|
Give Review
Doctor Anita Deswal, MD works in the field of Cardiology. She received 2 awards: "Top Doctors:SE Texas" and "Fellow (FACC)". Anita Deswal has written publications. She has 83 publications published with PubMed. The lastest paper is: 'Quantification of the myocardial response to low-dose dobutamine using tissue Doppler echocardiographic measures of velocity and velocity gradient.'
Publications
- Prognostic Importance of Changes in Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone.
- Provider Type and Quality of Outpatient Cardiovascular Disease Care: Insights From the NCDR PINNACLE Registry.
- Coronary Artery Disease Performance Measures and Statin Use in Patients With Recent Percutaneous Coronary Intervention or Recent Coronary Artery Bypass Grafting (from ...
- Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular Disease: insights from the National Cardiovascular Dis...
- Alcohol consumption and risk of Heart failure: the Atherosclerosis Risk in Communities Study.
- Gender disparities in evidence-based statin therapy in patients with cardiovascular Disease.
- Relation between playing position and Coronary artery calcium scores in retired national football league players.
- Pre-Morbid Body Mass Index and Mortality After Incident Heart Failure: The ARIC Study.
- Circulating Collagen Biomarkers as Indicators of Disease Severity in Pulmonary Arterial Hypertension.
- Effects of Spironolactone Treatment in Elderly Women with Heart Failure and Preserved Left Ventricular Ejection Fraction.
- Prognostic significance of hyponatremia among ambulatory patients with Heart failure and preserved and reduced ejection fractions.
- Revascularization improves mortality in elderly patients with Acute myocardial infarction complicated by cardiogenic shock.
- Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Renal Dysfunction: The ROSE Acute Heart Failure Randomized Trial.
- Worsening renal function is not associated with response to treatment in acute Heart failure.
- Incident cancer in patients with Heart failure: causation or mere association?
- Patients with severe chronic kidney disease benefit from early revascularization after Acute coronary syndrome.
- Lack of definitive evidence for the use of renin-angiotensin system antagonists for Heart failure with preserved ejection fraction.
- Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in Heart failure with preserved ejection fraction: a randomized clinical trial.
- Association Between Preoperative Diuretic Use and In-hospital Outcomes After Cardiac Surgery.
- Lifestyle Modification with Diet and Exercise in Obese Patients with Heart Failure - A Pilot Study.
- Case report: isolated cardiac amyloidosis: an enigma unravelled.
- Obesity, leptin, and incident Heart failure.
- Results of the Randomized Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction Trial (RAAM-PEF).
- New predictive models of Heart failure mortality using time-series measurements and ensemble models.
- Association of systolic blood pressure with mortality in patients with Heart failure with reduced ejection fraction: a complex relationship.
- Diuretic strategies in patients with acute decompensated Heart failure.
- Cognitive-behavioral therapy for Chronic cardiopulmonary conditions: preliminary outcomes from an open trial.
- A prospective echocardiographic evaluation of pulmonary Hypertension in chronic hemodialysis patients in the United States: prevalence and clinical significance.
- Metformin use and mortality in ambulatory patients with diabetes and Heart failure.
- Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable Heart failure.
- The potentially modifiable burden of incident Heart failure due to obesity: the atherosclerosis risk in communities study.
- Predicting quality of life in veterans with Heart failure: the role of disease severity, depression, and comorbid anxiety.
- Digoxin treatment in Heart failure - unveiling risk by cluster analysis of DIG data.
- Mortality after hospitalization for Heart failure in blacks compared to whites.
- Comparison of patients with Heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus.
- Depression and anxiety in ambulatory patients with Heart failure.
- Relationship of hemoglobin A1C and mortality in Heart failure patients with diabetes.
- Recognition and treatment of depression and anxiety symptoms in Heart failure.
- Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with Heart failure.
- Reduction in BNP levels with treatment of decompensated Heart failure and future clinical events.
- Biomarkers of inflammation in Heart failure.
- Treatment of patients with Heart failure and preserved ejection fraction.
- The July effect and cardiac surgery: the effect of the beginning of the academic cycle on outcomes.
- The metabolic syndrome and mortality in an ethnically diverse Heart failure population.
- Decreasing body temperature predicts early rehospitalization in congestive Heart failure.
- Advances in the treatment of Heart failure with a preserved ejection fraction.
- Role and optimal dosing of angiotensin-converting enzyme inhibitors in Heart failure.
- Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic Cardiomyopathy.
- Anti-angiotensin therapy: new perspectives.
- The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and Heart failure.
- Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident.
- Role and optimal dosing of angiotensin-converting enzyme inhibitor therapy.
- Translation of clinical trial results into practice: temporal patterns of beta-blocker utilization for Heart failure at hospital discharge and during ambulatory follow...
- Racial variations in quality of care and outcomes in an ambulatory Heart failure cohort.
- Comparison of morbidity in women versus men with Heart failure and preserved ejection fraction.
- Obesity as a prognostic factor in chronic symptomatic Heart failure.
- Can valsartan reduce the occurrence of atrial fibrillation in Heart failure patients?
- Review: B-type natriuretic peptide consistently predicts death and cardiovascular events in Heart failure.
- Diastolic dysfunction and diastolic Heart failure: mechanisms and epidemiology.
- Long-term results of Coronary artery bypass grafting in patients with ischemic cardiomyopathy: the impact of renal insufficiency and noncardiac vascular disease.
- Variation by race in factors contributing to Heart failure hospitalizations.
- Comparison of outcomes of white versus black patients hospitalized with Heart failure and preserved ejection fraction.
- Impact of race on health care utilization and outcomes in veterans with congestive Heart failure.
- Angiotensin-receptor blockade in Acute myocardial infarction--a matter of dose.
- Experimental options in the treatment of Heart failure: the role of cytokine antagonism.
- Asymptomatic left ventricular dysfunction: an overlooked part of the continuum of Heart failure.
- Perils of the random experiment.
- Circulating levels of tumor necrosis factor correlate with indexes of depressed Heart rate variability: a study in patients with mild-to-moderate Heart failure.
- Plasma matrix metalloproteinase and inhibitor profiles in patients with Heart failure.
- The fragility of cardiovascular clinical trial results.
- New therapeutics for chronic Heart failure.
- Trials within trials: confirmatory subgroup analyses in controlled clinical experiments.
- Effects of vesnarinone on peripheral circulating levels of cytokines and cytokine receptors in patients with Heart failure: a report from the Vesnarinone Trial.
- Cytokines and cytokine receptors in advanced Heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).
- The role of anti-cytokine therapy in the failing Heart.
- Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced Heart failure.
- An overview of tumor necrosis factor alpha and the failing human Heart.
- Quantification of the myocardial response to low-dose dobutamine using tissue Doppler echocardiographic measures of velocity and velocity gradient.
- The role of cytokines in disease progression in Heart failure.
- Cardiac involvement in scleroderma.
- Safe use of clonidine, nifedipine and vitamin K in hepatic porphyria.
- Ranitidine and Acute intermittent porphyria.
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Top Doctors:SE Texas
- Fellow (FACC)
Education
-
University of Pittsburgh Medical Center -
All India Institute of Medical Sciences
Hospital
-
Michael E. DeBakey Veterans Affairs Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Siddharth K. Prakash, MD |
|
Dr. Rajeev Grover, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Harold A. Condara Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael W. Bungo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christie M. Ballantyne, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Edward T. Yeh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Angelo Nascimbene, MD |